Therefore, using a cross-sectional study, we aimed to study 1) the associations between LSFAs and VLSFAs and the risk of NAFLD in T2D patients; 2) whether the effects of fatty acids and insulin have an additive effect on the development of NAFLD under the context of T2D. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.